These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1341718)

  • 1. In vitro analysis of drug resistance in tumor cells from patients with acute myelocytic leukemia.
    Kristensen J; Jonsson B; Sundström C; Nygren P; Larsson R
    Med Oncol Tumor Pharmacother; 1992; 9(2):65-74. PubMed ID: 1341718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA).
    Larsson R; Kristensen J; Sandberg C; Nygren P
    Int J Cancer; 1992 Jan; 50(2):177-85. PubMed ID: 1730510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between cladribine (2-chlorodeoxyadenosine) and standard antileukemic drugs in primary cultures of human tumor cells from patients with acute myelocytic leukemia.
    Kristensen J; Nygren P; Liliemark J; Fridborg H; Killander A; Simonsson B; Oberg G; Larsson R
    Leukemia; 1994 Oct; 8(10):1712-7. PubMed ID: 7934168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of the fluorometric microculture cytotoxicity assay (FMCA) for cytotoxic drug sensitivity testing of tumor cells from patients with acute lymphoblastic leukemia.
    Nygren P; Kristensen J; Jonsson B; Sundström C; Lönnerholm G; Kreuger A; Larsson R
    Leukemia; 1992 Nov; 6(11):1121-8. PubMed ID: 1434793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome.
    Zwaan CM; Kaspers GJ; Pieters R; Hählen K; Janka-Schaub GE; van Zantwijk CH; Huismans DR; de Vries E; Rots MG; Peters GJ; Jansen G; Creutzig U; Veerman AJ
    Blood; 2002 Jan; 99(1):245-51. PubMed ID: 11756178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of cyclosporins as resistance modifiers in primary cultures of human haematological and solid tumours.
    Fridborg H; Jonsson B; Nygren P; Csoka K; Nilsson K; Oberg G; Kristensen J; Bergh J; Tholander B; Olsen L
    Br J Cancer; 1994 Jul; 70(1):11-7. PubMed ID: 8018519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro drug resistance in B cell chronic lymphocytic leukemia: a comparison with acute myelocytic and acute lymphocytic leukemia.
    Aleskog A; Larsson R; Höglund M; Kristensen J; Nygren P; Lindhagen E
    Anticancer Drugs; 2005 Mar; 16(3):277-83. PubMed ID: 15711179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro cytotoxic drug activity and in vivo pharmacokinetics in childhood acute myeloid leukemia.
    Lönnerholm G; Frost BM; Larsson R; Liliemark E; Nygren P; Peterson C
    Adv Exp Med Biol; 1999; 457():429-35. PubMed ID: 10500819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological modification of multi-drug resistance (MDR) in vitro detected by a novel fluorometric microculture cytotoxicity assay. Reversal of resistance and selective cytotoxic actions of cyclosporin A and verapamil on MDR leukemia T-cells.
    Larsson R; Nygren P
    Int J Cancer; 1990 Jul; 46(1):67-72. PubMed ID: 2194983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro testing of chemotherapeutic drug combinations in acute myelocytic leukaemia using the fluorometric microculture cytotoxicity assay (FMCA).
    Larsson R; Fridborg H; Kristensen J; Sundström C; Nygren P
    Br J Cancer; 1993 May; 67(5):969-74. PubMed ID: 8494730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro resistance to cytosine arabinoside, not to daunorubicin, is associated with the risk of relapse in de novo acute myeloid leukaemia.
    Klumper E; Ossenkoppele GJ; Pieters R; Huismans DR; Loonen AH; Rottier A; Westra G; Veerman AJ
    Br J Haematol; 1996 Jun; 93(4):903-10. PubMed ID: 8703824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of 2-chlorodeoxyadenosine (CdA) in primary cultures of human haematological and solid tumours.
    Larsson R; Fridborg H; Liliemark J; Csoka K; Kristensen J; de la Torre M; Nygren P
    Eur J Cancer; 1994; 30A(7):1022-6. PubMed ID: 7946567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro determination of cytotoxic drug response in ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA).
    Csóka K; Tholander B; Gerdin E; de la Torre M; Larsson R; Nygren P
    Int J Cancer; 1997 Sep; 72(6):1008-12. PubMed ID: 9378534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapeutic drug sensitivity testing of human leukemia cells in vitro using a semiautomated fluorometric assay.
    Larsson R; Nygren P; Ekberg M; Slater L
    Leukemia; 1990 Aug; 4(8):567-71. PubMed ID: 2388483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant cytotoxic activity in vitro of the EGFR tyrosine kinase inhibitor gefitinib in acute myeloblastic leukaemia.
    Lindhagen E; Eriksson A; Wickström M; Danielsson K; Grundmark B; Henriksson R; Nygren P; Aleskog A; Larsson R; Höglund M
    Eur J Haematol; 2008 Nov; 81(5):344-53. PubMed ID: 18637032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different types of non-P-glycoprotein mediated multiple drug resistance in children with relapsed acute lymphoblastic leukaemia.
    Pieters R; Hongo T; Loonen AH; Huismans DR; Broxterman HJ; Hählen K; Veerman AJ
    Br J Cancer; 1992 May; 65(5):691-7. PubMed ID: 1350207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of new anticancer drugs, exemplified by vinorelbine, using the fluorometric microculture cytotoxicity assay on human tumor cell lines and patient biopsy cells.
    Fridborg H; Nygren P; Dhar S; Csoka K; Kristensen J; Larsson R
    J Exp Ther Oncol; 1996 Sep; 1(5):286-95. PubMed ID: 9414416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro drug sensitivity testing of tumor cells from patients with non-Hodgkin's lymphoma using the fluorometric microculture cytotoxicity assay.
    Nygren P; Hagberg H; Glimelius B; Sundström C; Kristensen J; Christiansen I; Larsson R
    Ann Oncol; 1994; 5 Suppl 1():127-31. PubMed ID: 8172809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential in vitro sensitivity of human tumor and normal cells to chemotherapeutic agents and resistance modulators.
    Nygren P; Larsson R
    Int J Cancer; 1991 Jun; 48(4):598-604. PubMed ID: 2045203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of combined fludarabine, treosulfan and mitoxantrone resistance profile in childhood acute myeloid leukemia.
    Styczynski J; Wysocki M; Dluzniewska A; Juraszewska E; Balwierz W; Czyzewski K; Wieczorek M; Olejnik I; Krawczuk-Rybak M; Kuzmicz M; Kowalczyk J; Stefaniak J; Badowska W; Sonta-Jakimczyk D; Szczepanski T; Matysiak M; Stanczak E; Malinowska I; Wachowiak J; Konatkowska B; Gil L; Balcerska A; Kapuscinska L; Szczepanek J; Kolodziej B; Rafinska B; Kubicka M
    Anticancer Res; 2008; 28(3B):1927-31. PubMed ID: 18630483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.